Table 3. Compounds Designed to Lower the Clint in Human Hepatocytes.
Measured inhibition of pAKT formation using alphaLISA after 24 h of treatment.
Measured decrease in viability using CellTiter-Glo 2.0 (CTG) after 72 h of treatment.
Intrinsic clearance obtained from scaling in vitro half-lives from pooled hepatocytes.